Dementia News and Research

Latest Dementia News and Research

Rochester scientist wins major award for Alzheimer's research

A Rochester researcher whose work has opened up a whole new avenue in Alzheimer's disease research has received a major prize from the American Academy of Neurology.

15 Apr 2009

Non-drug treatment of Alzheimer's disease: Long-term benefit not proven

Whether people with Alzheimer's disease benefit in the long term from non-drug treatment interventions remains an unanswered question.

15 Apr 2009

Neurodegeneration study reveals targets of destruction

Scientists are reporting the strongest evidence to date that neurodegenerative diseases target and progress along distinct neural networks that normally support healthy brain function.

15 Apr 2009

Statins for the prevention of dementia

An increasing number of studies show that elevated serum cholesterol levels might be part of the cause of Alzheimer's disease, but a new review of studies says that, even so, the most successful class of cholesterol-lowering medicines will not stave off the condition.

14 Apr 2009

Severe hypoglycemia linked with higher risk of dementia for seniors with diabetes

Having hypoglycemic (low blood sugar level) episodes that are severe enough to require hospitalization are associated with a greater risk of dementia for older adults with type 2 diabetes, according to a study in the April 15 issue of JAMA, the Journal of the American Medical Association.

14 Apr 2009

Enteral tube feeding for older patients with advanced dementia

Family members grappling with the decision to allow a feeding tube for a relative with advanced dementia will find little comfort from a new review of evidence.

14 Apr 2009

Hypoglycemic episodes increase dementia risk in seniors with type 2 diabetes

Hypoglycemic (low blood sugar) episodes that require a visit to the hospital are associated with increased risk of dementia in elderly patients with type 2 diabetes mellitus, according to a Kaiser Permanente Division of Research study in the Journal of the American Medical Association.

14 Apr 2009

Anti-clotting medications may be associated with brain microbleeds in older adults

Individuals who take aspirin or other medications that prevent blood clotting by inhibiting the accumulation of platelets appear more likely to have tiny, asymptomatic areas of bleeding in the brain, according to a report posted online today that will appear in the June print issue of Archives of Neurology.

13 Apr 2009

New small molecule approach to Alzheimer's disease treatment

New therapeutic approaches in Alzheimer's disease are urgently needed.

13 Apr 2009

Study finds multidrug-resistant gram-negative bacteria high in long-term care

The prevalence of a certain form of drug-resistant bacteria, called multidrug-resistant gram-negative (MDRGN) organisms, far surpassed that of two other common antimicrobial-resistant infections in long-term care facilities, according to a study conducted by researchers at Hebrew SeniorLife's Institute for Aging Research.

12 Apr 2009

Discovery of novel mechanisms that might causally link type-2 diabetes to Alzheimer's disease

A recent study by Mount Sinai faculty suggests that a gene associated with onset of type-2 diabetes also decreases in Alzheimer's disease dementia cases.

12 Apr 2009

Seroquel XR supplemental NDA recommended for approval

The U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) conducted a review of the safety and efficacy of supplemental new drug applications (sNDA) for Seroquel XR (quetiapine fumarate) extended-release tablets proposed for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD).

9 Apr 2009

Rogue Alzheimer's gene causes early brain changes

British scientists have found that some young adults who carry a certain genetic variant have an increased risk of developing Alzheimer's disease and distinct brain patterns and changes in their brain activity started decades before any symptoms appeared.

8 Apr 2009

Young adults at future risk of Alzheimer's have different brain activity

Young adults with a genetic variant that raises their risk of developing Alzheimer's Disease show changes in their brain activity decades before any symptoms might arise, according to a new brain imaging study by scientists from the University of Oxford and Imperial College London.

6 Apr 2009

Alzheimer's disease linked to mitochondrial damage

Investigators at the Burnham Institute for Medical Research (Burnham) have demonstrated that attacks on the mitochondrial protein Drp1 by the free radical nitric oxide-which causes a chemical reaction called S-nitrosylation-mediates neurodegeneration associated with Alzheimer's disease.

5 Apr 2009

Better tests needed to pinpoint memory problems

There's a lot more to memory than the ability to remember a story, who the President is, or what you ate for lunch.

2 Apr 2009

Discovery of mechanism of neurodegeneration in Alzheimer's disease

Tiny, toxic protein particles severely disrupt neurotransmission and inhibit delivery of key proteins in Alzheimer's disease, two separate studies by Marine Biological Laboratory (MBL) researchers have found.

29 Mar 2009

Add-on treatment may reduce treatment-associated weight gain caused by antipsychotic treatments

Antipsychotic drugs, such as olanzapine (Zyprexa), risperidone (Risperdal) and quetiapine (Seroquel), are commonly used to treat psychotic disorders like schizophrenia, but also bipolar disorder and even behavioral problems related to dementia.

29 Mar 2009

Radius starts Ppase 2a trial of RAD1901 in menopausal hot flashes

Radius Health ("Radius") announced today that the first patient has been dosed in the company's proof-of-concept Phase 2a study of RAD1901, an investigational selective estrogen receptor modulator (SERM) undergoing clinical evaluation for treatment of vasomotor symptoms (menopausal hot flashes).

24 Mar 2009

FDA approves Symbyax for treatment-resistant depression

The U.S. Food and Drug Administration (FDA) has approved a new indication for Symbyax (olanzapine and fluoxetine HCl capsules), Eli Lilly and Company has announced.

23 Mar 2009